Global Viral Vector Manufacturing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Viral Vector Manufacturing Market Research Report 2024
Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
According to MRAResearch’s new survey, global Viral Vector Manufacturing market is projected to reach US$ 678.8 million in 2033, increasing from US$ 487.9 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Viral Vector Manufacturing market research.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Viral Vector Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Segment by Type
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
Gene Therapy
Vaccinology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Viral Vector Manufacturing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Viral Vector Manufacturing market is projected to reach US$ 678.8 million in 2033, increasing from US$ 487.9 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Viral Vector Manufacturing market research.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Viral Vector Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Segment by Type
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
Segment by Application
Gene Therapy
Vaccinology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Viral Vector Manufacturing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source